10% Discount on Schrödinger’s online course to all our Members!
The Antibody Society has partnered with numerous conference organizers, including Informa Connect, Cambridge Healthtech Institute, Hanson Wade, and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.
We have also partnered with Schrödinger, and are pleased to offer 10% discounts to our members for their online course, Introduction to Computational Antibody Engineering.
To access the discount codes, please log into website and navigate to the Member discount codes page in the Members Only area.
Schrödinger’s online course, Introduction to Computational Antibody Engineering, will show how industry-leading computational molecular modeling solutions are used to aid in antibody discovery and design and how to incorporate these computational approaches into your research project. This course will also provide a chance to work hands-on with Schrödinger’s BioLuminate software.
The Antibody Society members save 20% off your booking – log into the Members Only area or contact membership@antibodysociety.org for the discount code.
September 2024
15th World Bispecific Summit | September 3-5, 2024
Radically Optimize Bi, Tri & Multispecific Antibodies to Enhance Target Discovery, Mechanistic Diversity & Clinical Translation to Maximize the Therapeutic Index & Enhance Combinations.
As of 2023, more than 10 bispecific antibodies have been successfully approved by the FDA, and more than 100 are currently in clinical trials, highlighting biopharma’s continued investment within bispecific therapeutics.
As we look to the future of bispecific drugs and focus on novel formats and exploring new mechanisms to differentiate from the crowd, the 15th World Bispecific Summit continues to be the industry’s one-stop-shop for all your strategic needs within bi, tri or multi-specifics or even bispecific ADCs or BiTEs.
Dates: September 3-5, 2024
Location: The Royal Sonesta Boston, 40 Edwin H Land Blvd, Cambridge, MA 02142, United States
Click here to download the event program:
Drug developers across discovery, preclinical and clinical development are joining forces once more to create an improved foothold in this exciting area of drug discovery and bring better and more efficacious bispecific drugs to patients across different disease indications.
Given the reach bispecific drugs can have, the hunt is on for novel targets that can transform the lives of patients, whether it’s new targets and combinations to improve the safety profile for haematological malignancies, overcoming the immunosuppressive microenvironment within solid tumors, or switching the immune system off in autoimmune disease.
Moving towards more personalized medicine, profiling bispecific candidates preclinically to ensure the developability has never been more important. Although time consuming, the benefits in the reduction of the risk and spend is huge in getting candidates into the clinic. Join this meeting to hear novel ideas and concepts, preclinical data, and clinical lessons to enhance the developability of your bispecific drug.
Click here to download the agenda
Click here and register your place. Take advantage of group discounts of up to 20% when sending your team of three or more!
The Antibody Society members save 10% off the conference registration – contact membership@antibodysociety.org or visit the Members Only section of the website to find the discount code.
The Antibody Series, September 4 – 6 2024
The Antibody Series (TAS) conference organized by FairJourney Biologics brings together leading industry and academia experts to exchange innovative ideas in antibody discovery and development.
The scientific program for TAS has been composed by 2024’s Chairman, Dr Paul Parren (CSO of Gyes) and will take place in the stunning Madeira Island; co-joined with over 4,000+ registered members online.
For registration and to learn more about this year’s agenda including special keynotes and antibody themes covered, such as New Technologies and Targets, Computation and Design, Antibody Engineering and more.
Visit: www.antibodyseries.com
Organized by the European Association for Cancer Research, the Next Generation Cancer Therapies conference will explore a breadth of new technical approaches to the identification and development of novel cancer therapeutics, including agents in early clinical development. The aim is to provide an accessible insight into recent developments in this rapidly evolving field, that aims to harness our insights from cancer research for the benefit of patients.
The target audience for this conference is: scientists in academia and industry who are interested in the most recent developments in cancer therapeutic discovery, including small molecule, degrader, peptide, and antibody technologies. The conference will include several novel antitumour approaches in early clinical development.
Join us online on 24 and 25 September to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 29 July and register before 09 September to secure your place.
Deadlines: Abstract submission deadline: 29 July 2024 Registration deadline: 09 September 2024
October 2024
Antibody Engineering & Therapeutics Asia Hybrid 21 – 23 October 2024 | Japan, The Westin Miyako Kyoto.
-
Bispecific and Multispecific Antibodies.
-
Clinical Antibody and ADC Programs and Lessons Learned.
-
AI-Guided Antibody Discovery & Engineering.
-
Antibody Engineering, Discovery and Selection.
-
Alternative Non-Antibody Scaffolds.
Registration fees increase each month leading up to the conference. So, the sooner you secure your spot, the more you save.
Members of The Antibody Society receive a 15% discount on the conference registration.
Contact us at membership@antibodysociety.org for the discount code!
We look forward to seeing you there! For more details, check out the event website.
Integrate Computational Biology, Generative AI & Machine Learning to Revolutionize Biologics Drug Discovery & Development.
With the transformative impact of AI-driven approaches in enhancing predictability, optimizing molecular design, and mitigating inherent risks in drug development pipelines, the CDD for Biologics summit is an indispensable platform for industry leaders to collaborate, innovate, and propel drug discovery forward amidst this era of computational excellence.
Members of The Antibody Society receive a 10% discount on conference registration for the CDD for Biologics Summit.
You can find the discount code in the members-only section under Member Discount Codes.
November 2024
15th World ADC November 4 – 7, San Diego, 2024.
Antibody-drug conjugates are receiving unrivalled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and Astellas’ PADCEV, all alongside a frenzy of companies entering the field and billion-dollar partnerships and M&As from Pfizer, AbbVie, J&J, Merck, Genmab, Ipsen and beyond, ADCs have firmly positioned themselves at the forefront of oncology R&D and dealmaking.
Returning as industry’s definitive ADC forum from early discovery to late-phase manufacturing, the 15th World ADC San Diego is the world-leading, largest, and most comprehensive ADC-focused conference to maximize the therapeutic window of ADCs. Whether you have just ventured into the ADC space or are an ADC guru, you’ll leave this meeting with the insight and connections needed to overcome your challenges and make impactful strides in your work.
Gain exclusive access to the full event guide to view the full agenda with 120+ industry-leading speakers leading 6 end-to-end development content tracks:
- Discovery: Uncover cutting-edge developments in ADC payloads, linkers, and site-specific conjugation technologies to ride the tidal wave of ADC design and chemistry innovation with Heidelberg Pharma, Sutro Biopharma, and ADC Therapeutics.
- Cellular Biology: Discover novel ADC target discovery and efficiently engineer antibody properties to elevate your ADC development for novel target and therapeutic applications with Innovent Biologics, Oxford BioTherapeutics, and SOTIO Biotech.
- Translational: Evaluate ADC safety and efficacy characterization, and preclinical model selection and predictiveness to minimize the translational mismatch and supercharge successful ADC progression into the clinic with Daiichi Sankyo, AstraZeneca, and Genentech.
- Clinical: Deep-dive into brand-new early and late-stage clinical data, contextualize clinical performance, and explore ADC dose escalation to best categorize what makes a clinically effective ADC with AbbVie, Ipsen, and Mythic Therapeutics.
- Process & Analytical Development: Explore analytical characterization of ADC DAR and impurities, and learn to streamline drug-linker and conjugation process optimization to reinvigorate your ADC product quality with Mersana Therapeutics, BMS, and GlaxoSmithKline.
- Manufacturing & Supply Chain: Understand ADC manufacturing risk management and scale-up, selection criteria for CDMO partners, and regulatory CMC strategy to equip you with robust and efficient manufacturing practices under accelerated ADC development timelines with Exelixis, Merck, and Pfizer.
Access to the complete agenda here including a 8-tracked seminar day and 10 industry-beating workshops.
Don’t miss out on the chance to reunite with the antibody-drug conjugate community while reflecting on the exciting year that ADCs have had, and building momentum for the future of this innovative field.
Members of The Antibody Society receive a 10% discount on conference registration. You can find the discount code in the members-only section under Member Discount Codes.
Biologics Symposium 2024
Join the Promega team and fellow research scientists for our 8th Biologics Symposium.
Hear guest speakers discuss their latest research and innovation in biotherapeutics. Learn about new tools being developed in Promega R&D to help the development of biologic therapeutics, including monoclonal antibodies, cell therapy and gene therapy.
There will also be dedicated time for networking with fellow researchers in the biologics field. The event is free to attend.
December 2024
Antibody Engineering & Therapeutics USA 2024, December 15-18, 2024 | Marriott Marquis, San Diego
January 2025
PepTalk: The Protein Science and Production Week
January 13-16, 2025 | San Diego, CA | CHI-PepTalk.com
PepTalk: The Protein Science and Production Week is the premier conference dedicated to advancing biotherapeutic discovery and development. With over two decades of experience, PepTalk provides comprehensive programming and innovative solutions that bridge biotherapeutic research and practical application. Throughout the week, precise and dedicated pipelines offer symposia, conference tracks, and training seminars focused on protein expression, production platforms, lab automation for higher throughput, analytical methods including developability and characterization, antibody discovery and development, and new this year, targeted therapies and drug delivery systems. Learn from expert speakers, engage with a devoted community, and gain valuable tools to propel your research forward.
Experience four days of immersive learning, world-class presentations, poster sessions, keynotes, roundtable sessions, panel discussions, exhibitions, and unparalleled networking opportunities.
The Antibody Society members save 10% off the conference registration – contact membership@antibodysociety.org or visit the Members Only section of the website to find the discount code.
